N-Acyl amino acids and their impact on biological processes

BioFactors

Volumn 40, Issue 4, 2014, Pages 381-388

  Hanuš, Lumír ^a   Shohami, Esther ^a   Bab, Itai ^a   Mechoulam, Raphael ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

N acyl taurines; N arachidonoyl glycine; N arachidonoyl serine; N oleoyl serine; Osteoporosis; Traumatic brain injury

Indexed keywords

AMIDE; GLYCINE; N ACYLAMINO ACID; NEUROPROTECTIVE AGENT; SERINE DERIVATIVE; TAURINE DERIVATIVE; VASODILATOR AGENT; ARACHIDONIC ACID DERIVATIVE; N-ARACHIDONOYL L-SERINE; N-ARACHIDONYLGLYCINE; OLEIC ACID; SERINE; TAURINE;

ANTINOCICEPTION; HUMAN; LIPIDOMICS; MAMMAL; NEUROPROTECTION; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; VASODILATATION; ANALOGS AND DERIVATIVES; ANIMAL; DIET; NUTRITIONAL STATUS; PHYSIOLOGY;

ANIMALS; ARACHIDONIC ACIDS; DIET; GLYCINE; HUMANS; NUTRITIONAL STATUS; OLEIC ACIDS; SERINE; TAURINE;

EID: 84906791330     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1166     Document Type: Review

References (49)

1. Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., et al. (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
2. Kleberg, K., Hassing, H. A., and Hansen, H. S. Classical endocannabinoid-like compounds and their regulation by nutrients. BioF, in press.
3. Tan, B., Bradshaw, H. B., Rimmerman, N., Srinivasan, H., Yu, Y. W., et al. (2006) Targeted lipidomics: discovery of new fatty acyl amides. AAPS J. 8, E461-E465.
4. Tan, B., O'Dell, D. K., Yu, Y. W., Monn, M. F., Hughes, H. V., et al. (2010) Identification of endogenous acyl amino acids based on a targeted lipidomics approach. J. Lipid Res. 51, 112-119.
5. Sugiura, T., Kobayashi, Y., Oka, S., and Waku, K. (2002) Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot. Essent. Fatty Acids 66, 173-192.
6. Milman, G., Maor, Y., Abu-Lafi, S., Horowitz, M., Gallily, R., et al. (2006) N-Arachidonoyl l-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proc. Natl. Acad. Sci. USA 103, 2428-2433.
7. McCue, J. M., Driscoll, W. J., and Mueller, G. P. (2009) In vitro synthesis of arachidonoyl amino acids by cytochrome c. Prostaglandins Other Lipid Mediat. 90, 42-48.
8. Cohen-Yeshurun, A., Willner, D., Trembovler, V., Alexandrovich, A., Mechoulam, R., et al. (2013) N-Arachidonoyl-l-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury. J. Cereb. Blood Flow Metab. 33, 1242-1250.
9. Golech, S. A., McCarron, R. M., Chen, Y., Bembry, J., Lenz, F., et al. (2004) Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Res. Mol. Brain Res. 132, 87-92.
10. Chen, Y., McCarron, R. M., Ohara, Y., Bembry, J., Azzam, N., et al. (2000) Human brain capillary endothelium: 2-arachidonoglycerol (endocannabinoid) interacts with endothelin-1. Circ. Res. 87, 323-327.
11. McHugh, D., Hu, S. S., Rimmerman, N., Juknat, A., Vogel, Z., et al. (2000) N-Arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor. BMC Neurosci. 11, 44.
12. Panikashvili, D., Simeonidou, C., Ben-Shabat, S., Hanuš, L., Breuer, A., et al. (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413, 527-531.
13. Shohami, E., Cohen-Yeshurun, A., Magid, L., Algali, M., and Mechoulam, R. (2011) Endocannabinoids and traumatic brain injury. Br. J. Pharmacol. 163, 1402-1410.
14. Cohen-Yeshurun, A., Trembovler, V., Alexandrovich, A., Ryberg, E., Greasley, P. J., et al. (2011) N-Arachidonoyl-l-serine is neuroprotective after traumatic brain injury by reducing apoptosis. J. Cereb. Blood Flow Metab. 31, 1768-1777.
15. Zhang, X., Maor, Y., Wang, J. F., Kunos, G., and Groopman, J. E. (2010) Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator. Br. J. Pharmacol. 160, 1583-1594.
16. + channels. J. Pharmacol. Exp. Ther. 328, 351-361.
17. Patinkin, D., Milman, G., Breuer, A., Fride, E., and Mechoulam, R. (2008) Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation. Eur. J. Pharmacol. 595, 1-6.
18. McHugh, D. and Ross, R. A. (2009) Endogenous cannabinoids and neutrophil chemotaxis. Vitam. Horm. 81, 337-365.
19. Bradshaw, H. B., Rimmerman, N., Hu, S. S.-J., Burstein, S., and Walker, J. M. (2009) Novel endogenous N-acyl glycines: identification and characterization. Vitam. Horm. 81, 191-205.
20. Bradshaw, H. B., Rimmerman, N., Hu, S. S.-J., Benton. V. M., Stuart, J. M., et al. (2009) The endocannabinoid anandamide is a precursor for the signaling lipid N-arachidonoyl glycine by two distinct pathways. BMC Biochem. 10, 14.
21. Waluk, D. P., Schultz, N., and Hunt, M. C. (2010) Identification of glycine N-acyltransferase-like 2 (GLYATL2) as a transferase that produces N-acyl glycines in humans. FASEB J. 24, 2795-2280.
22. Waluk, D. P., Sucharski, F., Sipos, L., Silberring, J., and Hunt, M. C. (2012) Reversible lysine acetylation regulates activity of human glycine N-acyltransferase-like 2 (hGLYATL2): implications for production of glycine-conjugated signaling molecules. J. Biol. Chem. 287, 16158-16167.
23. Barbara, G., Alloui, A., Nargeot, J., Lory, P., Eschalier, A., et al. (2009) T-type calcium channel inhibition underlies the analgesic effects of the endogenous lipoamino acids. J. Neurosci. 29, 13106-13114.
24. Cazade, M., Nuss, C. E., Bidaud, I., Renger, J. J., Uebele, V. N., et al. (2014) Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2. Mol. Pharmacol. 85, 218-225.
25. McHugh, D., Wager-Miller, J., Page, J., and Bradshaw, H. B. (2012) siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl-glycine induced cell migration. J. Mol. Signal. 7, 1-5.
26. 9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells. Br. J. Pharmacol. 165, 2414-2424.
27. 9-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18. Front. Pharmacol. 4, 162.
28. Takenouchi, R., Inoue, K., Kambe, Y., and Miyata, A. (2012) N-arachidonoyl glycine induces macrophage apoptosis via GPR18. Biochem. Biophys. Res. Commun. 418, 366-371.
29. Lu, V. B., Puhl, H. L. III, and Ikeda, S. R. (2013) N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways. Mol. Pharmacol. 83, 267-282.
30. Penumarti, A. and Abdel-Rahman, A. A. (2014) The novel endocannabinoid receptor GPR18 is expressed in the rostral ventrolateral medulla and exerts tonic restraining influence on blood pressure. J. Pharmacol. Exp. Ther. 349, 29-38.
31. Caldwell, M. D., Hu, S. S.-J., Viswanathan, S., Bradshaw, H. B., Kelly, M. E. M., et al. (2013) A GPR18-based signalling system regulates IOP in murine eye. Br. J. Pharmacol. 169, 834-843.
32. Jeong, H.-J., Vandenberg, R. J., and Vaughan, C. W. (2010) N-Arachidonoyl-glycine modulates synaptic transmission in superficial dorsal horn. Br. J. Pharmacol. 161, 925-935.
33. Bradshaw, H. B. and Allard, C. (2011) Endogenous cannabinoid production in the rat female reproductive tract is regulated by changes in the hormonal milieu. Pharmaceuticals 4, 933-949.
34. 2+ entry into endothelial cells and activates BKCa channels independently of GPCRs. Br. J. Pharmacol. 169, 933-948.
35. 2+ entry by preventing STIM1-Orai1 interaction. J. Cell Sci. 126, 879-888.
36. Stuart, J. M., Bradshaw, H. B., Paris, J. J. and Frye, C. Brain levels of prostaglandins, endocannabinoids, and related lipids are affected by mating strategies. Int. J. Endocrinol., in press.
37. Huber, F. R. and Schenk, L. M. (1961) Process for manufacture of N-acyl taurines. U.S. Pat. 3, 013, 035 (December 12).
38. Saghatelian, A. and Cravatt, B. F. (2005) Discovery metabolite profiling-forging functional connections between the proteome and metabolome. Life Sci. 77, 1759-1766.
39. Saghatelian, A., McKinney, M. K., Bandell, M., Patapoutian, A., and Cravatt, B. F. (2006) A FAAH-regulated class of N-acyl taurines that activates TRP ion channels. Biochemistry 45, 9007-9015.
40. McKinney, M. K. and Cravatt, B. F. (2006) Structure-based design of a FAAH variant that discriminates between the N-acyl ethanolamine and taurine families of signaling lipids. Biochemistry 45, 9016-9022.
41. Long, J. Z., LaCava, M., Jin, X., and Cravatt, B. F. (2011) An anatomical and temporal portrait of physiological substrates for fatty acid amide hydrolase. J. Lipid Res. 52, 337-344.
42. Zhou, X., Xu, T., Wen, K., Yang, X.-W., Xu, S.-H., et al. (2010) New N-acyl taurine from the sea urchin Glyptocidaris crenularis. Biosci. Biotechnol. Biochem. 74, 1089-1091.
43. Waluk, D. P., Vielfort, K., Derakhshan, S., Aro, H., and Hunt M. C. (2013) N-Acyl taurines trigger insulin secretion by increasing calcium flux in pancreatic β-cells. Biochem. Biophys. Res. Commun. 430, 54-59.
44. Chatzakos, V., Slaetis, K., Djureinovic, T., Helleday, T., and Hunt, M.C. (2012) N-Acyl taurines are anti-proliferative in prostate cancer cells. Lipids 47, 355-361.
45. Bab, I., Smoum, R., Bradshaw, H., and Mechoulam R. (2011) Skeletal lipidomics: regulation of bone metabolism by fatty acid amide family. Br. J. Pharmacol. 163, 1441-14416.
46. Bajayo, A., Bar, A., Denes, A., Bachar, M., Kram, V., et al. (2012) Skeletal parasympathetic innervation communicates central IL1 signals regulating bone mass accrual. Proc. Natl. Acad. Sci. USA 109, 15455-15460.
47. Trichopoulou, A., Georgiou, E., Bassiakos, Y., Lipworth L., Lagiou, P., et al. (1997) Energy intake and monounsaturated fat in relation to bone mineral density among women and men in Greece. Prev. Med. 26, 395-400.
48. Smoum, R., Bar, A., Tan, B., Milman, G., Attar-Namdar, M., et al. (2010) Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proc. Natl. Acad. Sci. USA 107, 17710-17715.
49. Mechoulam, R. and Parker, L. (2013) The endocannabinoid system and the brain. Annu. Rev. Psychol. 64, 21-47.